Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
33%
Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (33.3%)
N/A2 (66.7%)

Trials by Status

completed267%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingnot_applicable

High - Flow Nasal Cannula Versus Conventional Nasal Cannula During Endobronchial Ultrasound Procedure

NCT06637280
completednot_applicable

Evaluation of Different Methods for Preoxygenation

NCT05839665
completedphase_2

To Determine the Efficacy of the TwinGuard in Oxygen Delivery During and Post Endoscopic Procedure

NCT00619606

Clinical Trials (3)

Showing 3 of 3 trials
NCT06637280Not Applicable

High - Flow Nasal Cannula Versus Conventional Nasal Cannula During Endobronchial Ultrasound Procedure

Recruiting
NCT05839665Not Applicable

Evaluation of Different Methods for Preoxygenation

Completed
NCT00619606Phase 2

To Determine the Efficacy of the TwinGuard in Oxygen Delivery During and Post Endoscopic Procedure

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3